Voyager Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 7.38K shares, a 64.38% decline year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 29.06K shares, a 5.13% increase year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was -32.40K shares, a 224.83% decline year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 87.45K shares, a 169.08% increase year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 91.49K shares, a 14.36% decline from fiscal 2024.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 106.83K shares, a 72.30% decline from fiscal 2023.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 385.65K shares, a 333.26% increase from fiscal 2022.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 89.01K shares, a 2235.66% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 7.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 91.49K shares 10-K · filed 2026-03-09 |
| 2025-09-30 | 29.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 104.84K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-06-30 | -32.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 103.42K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-03-31 | 87.45K shares 10-Q · filed 2026-05-07 | 161.78K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 20.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 106.83K shares 10-K · filed 2025-03-11 |
| 2024-09-30 | 27.64K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 94.16K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 25.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 193.77K shares derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | 32.50K shares 10-Q · filed 2024-05-13 | 366.16K shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 8.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 385.65K shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 127.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 386.77K shares derived: sum of 4 quarters · filed 2023-11-06 |
| 2023-06-30 | 198.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 264.86K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 51.99K shares 10-Q · filed 2023-05-09 | 129.52K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 9.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 89.01K shares 10-K · filed 2023-03-07 |
| 2022-09-30 | 5.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 79.84K shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 63.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 74.50K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 11.48K shares 10-Q · filed 2022-05-04 | 11.48K shares derived: sum of 4 quarters · filed 2022-05-04 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 3.81K shares 10-K · filed 2022-03-08 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 17.96K shares derived: sum of 4 quarters · filed 2021-11-02 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 68.73K shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 3.81K shares 10-Q · filed 2021-05-10 | 229.21K shares derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-12-31 | 14.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 228.44K shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 50.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 225.23K shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 160.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 324.97K shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 3.04K shares 10-Q · filed 2020-05-06 | 221.95K shares derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-12-31 | 10.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | 250.28K shares 10-K · filed 2020-03-03 |
| 2019-09-30 | 150.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 263.42K shares derived: sum of 4 quarters · filed 2019-11-06 |
| 2019-06-30 | 57.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 226.96K shares derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | 31.36K shares 10-Q · filed 2019-05-07 | 282.81K shares derived: sum of 4 quarters · filed 2019-05-07 |
| 2018-12-31 | 24.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 384.19K shares 10-K · filed 2019-02-26 |
| 2018-09-30 | 114.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | |
| 2018-06-30 | 113.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | |
| 2018-03-31 | 132.73K shares 10-Q · filed 2018-05-10 | |
| 2017-09-30 | 32.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | |
| 2017-06-30 | 26.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | |
| 2017-03-31 | 70.94K shares 10-Q · filed 2017-05-09 | |
| 2016-09-30 | 6.71K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | |
| 2016-06-30 | 12.41K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | |
| 2016-03-31 | 500.00 shares 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |